| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.4 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | -0.099 | 0.4 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.039 | 0.4 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.4 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |